RBC ups Theratechnologies to buy
March 25, 2010 by stephenkilmer · Leave a Comment
Citing a recent sell-off and upcoming milestones, RBC Capital Markets upgraded Theratechnologies (TSX:TH) to “outperform” from “sector perform,” but kept its price target unchanged at $6.50. The shares finished at $5.09 on Wednesday after touching a 52-week high of $5.61 earlier this month. “Theratechnologiesis in the enviable position of having a number of important upcoming [...]
Listen to BioTuesdays 
